Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.75 USD | -2.90% | -12.81% | -28.10% |
05-10 | UBS Trims Price Target on Evolent Health to $44 From $46, Keeps Buy Rating | MT |
05-09 | Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.10% | 2.72B | |
+5.89% | 32.95B | |
+18.02% | 7.82B | |
+30.15% | 4.17B | |
-18.15% | 1.41B | |
-33.33% | 1.15B | |
+9.61% | 980M | |
-37.56% | 873M | |
-26.41% | 831M | |
-19.89% | 688M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Cowen Raises Evolent Health's Price Target to $50 From $48, Maintains Outperform Rating